Gonorrhea
Sexually Transmitted Disease Surveillance 2002
Division of STD Prevention
Gonorrhea — Rates: United States, 1970–2002 and the Healthy People 2010 objective
Rate (per 100,000 population)
Gonorrhea2010 Objective
0
100
200
300
400
500
1970 73 76 79 82 85 88 91 94 97 2000
Note: The Healthy People 2010 objective for gonorrhea is 19.0 cases per 100,000 population.
Gonorrhea — Rates by state: United States and outlying areas, 2002
Rate per 100,000population
<=19.019.1-100.0>100.0
VT 16.1 NH 9.7 MA 51.1 RI 85.9 CT 95.2 NJ 93.8 DE 201.1 MD 176.6
Guam 31.7
Puerto Rico 10.8 Virgin Is. 45.1
(n= 9)(n= 20)(n= 24)
227.5
102.2
74.0171.5
72.6 81.6
133.6
224.6
61.1
7.3
193.5 121.6
50.6
102.1 93.3
254.8
11.1
148.6
62.0
241.7
160.0
13.6
91.4 99.5
80.4
115.1
192.9
11.2
193.8
135.1
26.6
108.2
228.1
34.8
164.3
129.4
16.7
147.8
49.6
53.9
118.2
13.2
Note: The total rate of gonorrhea for the United States and outlying areas (Guam, Puerto Rico and Virgin Islands) was 123.4 per 100,000 population. The Healthy People 2010 objective is 19.0 cases per 100,000 population.
Gonorrhea — Rates by county: United States, 2002
Note: The Healthy People 2010 objective for gonorrhea is 19.0 cases per 100,000 population.
Rate per 100,000population
<=19.019.1-100.0 (n=1033)
(n=730)
(n=1376)
>100.0
Gonorrhea — Rates by region: United States, 1981–2002 and the Healthy People 2010 objective
Rate (per 100,000 population)
WestMidwestNortheastSouth2010 Objective
0
120
240
360
480
600
1981 83 85 87 89 91 93 95 97 99 2001
Gonorrhea — Rates by sex: United States, 1981–2002 and the Healthy People 2010 objective
Rate (per 100,000 population)
MaleFemale2010 Objective
0
120
240
360
480
600
1981 83 85 87 89 91 93 95 97 99 2001
Gonorrhea — Rates by race and ethnicity: United States, 1981–2002 and the Healthy People 2010 objective
Rate (per 100,000 population)
WhiteBlackHispanicAsian/Pac IslAm Ind/AK Nat2010 Objective
0
500
1,000
1,500
2,000
2,500
1981 83 85 87 89 91 93 95 97 99 2001
Gonorrhea — Age- and sex-specific rates: United States, 2002
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-147.4
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
287.9
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
538.1
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
320.4
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
199.2
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
131.4
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
92.1
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
48.1
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
17.3
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
4.4
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
124.5
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14 46.6
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
675.6
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
650.3
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
251.4
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
113.1
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
57.4
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
31.3
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
10.6
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
2.1
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
0.8
Men Rate (per 100,000 population) Women
Age750 600 450 300 150 0 0 150 300 450 600 750
Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14
125.5
Gonorrhea — Positivity among 15-24 year old women tested in family planning clinics by state: United States and outlying areas,
2002
Positivity (%)
See *<1.01.0-1.9>=2.0
VT 0.2 NH 0.1 MA RI CT 0.8 NJ 1.3 DE MD DC 1.2
Puerto Rico 0.2 Virgin Is. 2.5
(n= 15)(n= 21)(n= 10)(n= 7)
2.3
0.6
1.5
0.9 0.5
0.6
2.4
0.1
1.8 1.2
0.7
0.7 0.7
2.4
1.0
2.8
0.9
0.6
0.6 1.2
0.7
1.5
0.7
0.9
1.4
0.7
1.0
0.2 2.8
2.7
0.4
*States reported gonorrhea positivity data on less than 500 women aged 15-24 years during 2002, except for Pennsylvania and Puerto Rico which submitted gonorrhea positivity data for April - December 2002 only.
SOURCE: Regional Infertility Prevention Projects; Office of Population Affairs; Local and State STD Control Programs; Centers for Disease Control and Prevention
Gonococcal Isolate Surveillance Project (GISP) — Location of participating clinics and regional laboratories: United States, 2002
Tripler AMC
Portland
San Francisco
Las Vegas
Long Beach
Orange Co.
San DiegoPhoenix
Anchorage
Honolulu
Albuquerque
Dallas
New Orleans
STD Clinics
BirminghamAtlanta
Ft. BraggGreensboro
BaltimoreCincinnati
St. Louis
ChicagoPhiladelphia
ClevelandMinneapolis
Denver
Miami
Seattle
Laboratories
Gonococcal Isolate Surveillance Project (GISP) — Penicillin and tetracycline resistance among GISP isolates, 2002
Note: PPNG=penicillinase-producing N. gonorrhoeae; TRNG=plasmid-mediated tetracycline resistant N. gonorrhoeae; PPNG-TRNG=plasmid-mediated penicillin and tetracycline resistant N. gonorrhoeae; PenR=chromosomally mediated penicillin resistant N. gonorrhoeae; TetR=chromosomally mediated tetracycline resistant N. gonorrhoeae; CMRNG=chromosomally mediated penicillin and tetracycline resistant N. gonorrhoeae.
Susceptible
PPNG
TRNG
PPNG/TRNG
PenR
TetR
CMRNG
82.0%
1.2%
4.3%
0.7%2.1%
5.5%
4.2%
Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate
resistance to ciprofloxacin, 1990–2002
Percent
Resistance
Intermediate resistance
0.0
0.8
1.6
2.4
3.2
4.0
1990 91 92 93 94 95 96 97 98 99 2000 01 02
Note: Resistant isolates have ciprofloxacin MICs > 1 g/ml. Isolates with intermediate resistance have ciprofloxacin MICs of 0.125 - 0.5 g/ml. Susceptibility to ciprofloxacin was first measured in GISP in 1990.
Gonococcal Isolate Surveillance Project (GISP) — Percent of men with gonorrhea who had a previous gonorrhea infection, 1991–2002
Percent
Ever*Last 12 months**
0
12
24
36
48
60
1991 92 93 94 95 96 97 98 99 2000 01 02
*Data first collected in 1991.**Data first collected in 1992.